Vascular dysfunction and heart failure: Epiphenomenon or etiologic agent?
- 1 March 2002
- journal article
- review article
- Published by Elsevier in American Heart Journal
- Vol. 143 (3) , 383-390
- https://doi.org/10.1067/mhj.2002.120780
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- HEART FAILURE: Epidemiology, aetiology, and prognosis of heart failureHeart, 2000
- Paracrine and autocrine effects of nitric oxide on myocardial functionPharmacology & Therapeutics, 2000
- ABC of heart failure: History and epidemiologyBMJ, 2000
- Serum From Patients With Severe Heart Failure Downregulates eNOS and Is ProapoptoticCirculation, 1999
- NITRIC OXIDE IN THE FAILING MYOCARDIUMCardiology Clinics, 1998
- Basic mechanisms in heart failure: The cytokine hypothesisJournal of Cardiac Failure, 1996
- Pathophysiological correlates of increased serum tumor necrosis factor in patients with congestive heart failure. Relation to nitric oxide-dependent vasodilation in the forearm circulation.Circulation, 1994
- Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life.Circulation Research, 1993
- Endothelin-1-induced vasoconstriction in humans. Reversal by calcium channel blockade but not by nitrovasodilators or endothelium-derived relaxing factor.Circulation, 1991
- Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factorNature, 1986